| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
NovaBridge Biosciences
13D/A
NBP · 44975P103
|
4.9% |
11/5/2026
Event 11/5/2026
|
||||
| HHLR Advisors, Ltd. | 4.9% | |||||
| Hillhouse Investment Management, Ltd. | 4.9% | |||||
|
BeiGene, Ltd.
13D/A
ONC · 07725L102
|
4.9% |
5/13/2025
Event 5/9/2025
|
||||
| HHLR Advisors, Ltd. | 4.9% | |||||
| Hillhouse Investment Management, Ltd. | 4.9% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Agora, Inc.
13G/A
API · 00851L103
|
2.3% |
2/14/2025
Event 12/31/2024
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.